Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus

Journal of Virology

Volumn 81, Issue 22, 2007, Pages 12464-12471

  Zheng, Aihua ^a   Yuan, Fei ^a   Li, Yanqin ^a   Zhu, Fangfang ^a   Hou, Pingping ^a   Li, Jianqing ^a   Song, Xijun ^a   Ding, Mingxiao ^a   Deng, Hongkui ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; CLAUDIN 1; CLAUDIN 11; CLAUDIN 12; CLAUDIN 15; CLAUDIN 2; CLAUDIN 23; CLAUDIN 3; CLAUDIN 4; CLAUDIN 6; CLAUDIN 7; CLAUDIN 9; PROTEIN BEL7402; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR; CLAUDIN 9, HUMAN; MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; HEPATITIS C VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; TARGET CELL; VIRUS CELL INTERACTION; VIRUS IDENTIFICATION; VIRUS REPLICATION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHEMISTRY; GENETICS; HUMAN; LIVER; METABOLISM; MOLECULAR GENETICS; MONONUCLEAR CELL; MUTAGENESIS; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY; VIRUS ENTRY;

HEPATITIS C VIRUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL LINE, TUMOR; HEPACIVIRUS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; RECEPTORS, VIRUS; VIRUS INTERNALIZATION;

EID: 36048954580     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01457-07     Document Type: Article

References (38)

1. Amoroso, P., M. Rapicetta, M. E. Tosti, A. Mele, E. Spada, S. Buonocore, G. Lettieri, P. Pierri, P. Chionne, A. R. Ciccaglione, and L. Sagliocca. 1998. Correlation between virus genotype and chronicity rate in acute hepatitis C. J. Hepatol. 28:939-944.
2. Bartosch, B., J. Dubuisson, and F. L. Cosset. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197:633-642.
3. Bartosch, B., G. Verney, M. Dreux, P. Donot, Y. Morice, F. Penin, J. M. Pawlotsky, D. Lavillette, and F. L. Cosset. 2005. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J. Virol. 79:8217-8229.
4. Blackard, J. T., N. Kemmer, and K. E. Sherman. 2006. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44:15-22.
5. Chen, R. M., D. H. Zhu, and X. Z. Ye. 1975. The establishment and character of human hepacarcinoma cell line (BEL-7402) in vitro. Comm. Sci. 20:434-436.
6. Cormier, E. G., F. Tsamis, F. Kajumo, R. J. Durso, J. P. Gardner, and T. Dragic. 2004. CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA 101:7270-7274.
7. Evans, M. J., T. von Hahn, D. M. Tscherne, A. J. Syder, M. Panis, B. Wolk, T. Hatziioannou, J. A. McKeating, P. D. Bieniasz, and C. M. Rice. 2007. Claudin-1 is a hepatitis C virus receptor required for a late step in entry. Nature 446:801-805.
8. Furuse, M., K. Fujita, T. Hiiragi, K. Fujimoto, and S. Tsukita. 1998. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141:1539-1550.
9. Gonzalez-Mariscal, L., A. Betanzos, P. Nava, and B. E. Jaramillo. 2003. Tight junction proteins. Prog. Biophys. Mol. Biol. 81:1-44.
10. Gumbiner, B. M. 1993. Breaking through the tight junction barrier. J. Cell Biol. 123:1631-1633.
11. Hewitt, K. J., R. Agarwal, and P. J. Morin. 2006. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6:186.
12. Hong, Y. H., D. Hishikawa, H. Miyahara, Y. Nishimura, H. Tsuzuki, C. Gotoh, T. Iga, Y. Suzuki, S. H. Song, K. C. Choi, H. G. Lee, S. Sasaki, and S. G. Roh. 2005. Up-regulation of the claudin-6 gene in adipogenesis. Biosci. Biotechnol. Biochem. 69:2117-2121.
13. Hoofnagle, J. H. 2002. Course and outcome of hepatitis C. Hepatology 36:S21-S29.
14. Hsu, M., J. Zhang, M. Flint, C. Logvinoff, C. Cheng-Mayer, C. M. Rice, and J. A. McKeating. 2003. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. USA 100:7271-7276.
15. Kaiser, P., B. Niederost, B. Joos, V. von Wyl, M. Opravil, R. Weber, H. F. Gunthard, and M. Fischer. 2006. Equal amounts of intracellular and virion-enclosed hepatitis C virus RNA are associated with peripheral-blood mononuclear cells in vivo. J. Infect. Dis. 194:1713-1723.
16. Kato, T., T. Date, M. Miyamoto, Z. Zhao, M. Mizokami, and T. Wakita. 2005. Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J. Virol. 79:592-596.
17. Lauer, G. M., and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.
18. Lavillette, D., A. W. Tarr, C. Voisset, P. Donot, B. Bartosch, C. Bain, A. H. Patel, J. Dubuisson, J. K. Ball, and F. L. Cosset. 2005. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41:265-274.
19. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
20. Ling, C. Q., B. Li, C. Zhang, D. Z. Zhu, X. Q. Huang, W. Gu, and S. X. Li. 2005. Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma. Ann. Oncol. 16:109-115.
21. McKeating, J. A., L. Q. Zhang, C. Logvinoff, M. Flint, J. Zhang, J. Yu, D. Butera, D. D. Ho, L. B. Dustin, C. M. Rice, and P. Balfe. 2004. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J. Virol. 78:8496-8505.
22. Morita, K., M. Furuse, K. Fujimoto, and S. Tsukita. 1999. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. USA 96:511-516.
23. Morsica, G., G. Tambussi, G. Sitia, R. Novati, A. Lazzarin, L. Lopalco, and S. Mukenge. 1999. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 94:1138-1139.
24. Muller, H. M., E. Pfaff, T. Goeser, B. Kallinowski, C. Solbach, and L. Theilmann. 1993. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J. Gen. Virol. 74:669-676.
25. Op De Beeck, A., L. Cocquerel, and J. Dubuisson. 2001. Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol. 82:2589-2595.
26. Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941.
27. Qu, X. X., P. Hao, X. J. Song, S. M. Jiang, Y. X. Liu, P. G. Wang, X. Rao, H. D. Song, S. Y. Wang, Y. Zuo, A. H. Zheng, M. Luo, H. L. Wang, F. Deng, H. Z. Wang, Z. H. Hu, M. X. Ding, G. P. Zhao, and H. K. Deng. 2005. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. J. Biol. Chem. 280: 29588-29595.
28. Rahner, C., L. L. Mitic, and J. M. Anderson. 2001. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 120:411-422.
29. Rosa, D., S. Campagnoli, C. Moretto, E. Guenzi, L. Cousens, M. Chin, C. Dong, A. J. Weiner, J. Y. Lau, Q. L. Choo, D. Chien, P. Pileri, M. Houghton, and S. Abrignani. 1996. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target ceils. Proc. Natl. Acad. Sci. USA 93:1759-1763.
30. Rubinson, D. A., C. P. Dillon, A. V. Kwiatkowski, C. Sievers, L. Yang, J. Kopinja, D. L. Rooney, M. Zhang, M. M. Ihrig, M. T. McManus, F. B. Gertler, M. L. Scott, and L. Van Parijs. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33:401-406.
31. Scarselli, E., H. Ansuini, R. Cerino, R. M. Roccasecca, S. Acali, G. Filocamo, C. Traboni, A. Nicosia, R. Cortese, and A. Vitelli. 2002. The human scavenger receptor class B type 1 is a novel candidate receptor for the hepatitis C virus. EMBO J. 21:5017-5025.
32. Seeff, L. B. 1995. Natural history of viral hepatitis, type C. Semin. Gastrointest. Dis. 6:20-27.
33. Shao, G. Z., R. L. Zhou, Q. Y. Zhang, Y. Zhang, J. J. Liu, J. A. Rui, X. Wei, and D. X. Ye. 2003. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogene 22:5060-5069.
34. Simmonds, P., A. Alberti, H. J. Alter, F. Bonino, D. W. Bradley, C. Brechot, J. T. Brouwer, S. W. Chan, K. Chayama, D. S. Chen, et al. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
35. Volsset, C., N. Callens, E. Blanchard, A. Op De Beeck, J. Dubuisson, and N. Vu-Dac. 2005. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type 1. J. Biol. Chem. 280:7793-7799.
36. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager, and T. J. Liang. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
37. Zhang, J., G. Randall, A. Higginbottom, P. Monk, C. M. Rice, and J. A. McKeating. 2004. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78:1448-1455.
38. Zhu, X. F., B. F. Xie, J. M. Zhou, G. K. Feng, Z. C. Liu, X. Y. Wei, F. X. Zhang, M. F. Liu, and Y. X. Zeng. 2005. Blockade of vascular endothelial growth factor receptor signal pathway and antitumor activity of ON-III (2′,4′-dihydroxy-6′-methoxy-3′,5′- dimethylchalcone), a component from Chinese herbal medicine. Mol. Pharmacol. 67:1444-1450.